FDA — authorised 27 June 1952
- Application: NDA050141
- Marketing authorisation holder: KING PHARMS LLC
- Local brand name: BICILLIN L-A
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Bicillin C-R in United States
FDA authorised Bicillin C-R on 27 June 1952
Marketing authorisations
FDA — authorised 18 May 1953
- Application: NDA050138
- Marketing authorisation holder: KING PHARMS LLC
- Local brand name: BICILLIN C-R
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 31 December 1958
- Application: NDA050131
- Marketing authorisation holder: WYETH AYERST
- Local brand name: BICILLIN L-A
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Status: approved
Bicillin C-R in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Bicillin C-R approved in United States?
Yes. FDA authorised it on 27 June 1952; FDA authorised it on 18 May 1953; FDA authorised it on 31 December 1958.
Who is the marketing authorisation holder for Bicillin C-R in United States?
KING PHARMS LLC holds the US marketing authorisation.